PUBLISHER: KBV Research | PRODUCT CODE: 1593688
PUBLISHER: KBV Research | PRODUCT CODE: 1593688
The Europe Tele-epilepsy Market would witness market growth of 15.2% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Tele-epilepsy Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $85.9 million by 2031. The UK market is exhibiting a CAGR of 14.2% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.1% during (2024 - 2031).
At the heart of tele-epilepsy is the capacity to connect patients with epilepsy specialists through secure, high-definition video consultations, real-time data sharing, and advanced digital health tools. These devices enable healthcare clinicians to monitor seizure activity, adjust medications, and deliver prompt interventions without necessitating patients to travel long distances or wait for appointments.
For patients who are vulnerable to frequent, unpredictable seizures, this remote access is a significant improvement over traditional care, as it offers a level of flexibility and responsiveness that was previously unavailable. Tele-epilepsy also promotes a sense of continuity in care, as patients can maintain consistent communication with their providers and adhere to follow-up schedules that are frequently challenging to accomplish through in-person visits alone.
France has seen increased demand for tele-epilepsy, largely fueled by its government's efforts to reduce healthcare disparities in rural and underserved areas. The French Ministry of Health has actively supported telemedicine through the "Ma Sante 2022" plan, which aims to provide remote care options for patients in areas with limited access to specialists. As part of this initiative, the government has funded healthcare providers to establish tele-epilepsy services, ensuring that epilepsy patients can access specialized care regardless of their location. The French health insurance system also covers telemedicine consultations, supporting patient adoption. France's emphasis on reducing regional healthcare gaps and improving accessibility has positioned tele-epilepsy as essential for nationwide neurological care. Hence, the regional market will experience expedited growth in the coming years.
Based on Patient, the market is segmented into Adult and Pediatric. Based on End Use, the market is segmented into Healthcare Consumers, Hospitals Providers, and Payers. Based on Component, the market is segmented into Software, Hardware, and Services. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
Europe Tele-epilepsy Market Report Segmentation
By Patient
By End Use
By Component
By Country